| 2 The Sanofi-aventis Group profile |
| 3 Message from the Chairman |
| 10 Interview with the Chief Executive Officer |
| 14 2009 milestones |
| 16 Corporate governance |
| 19 2009 performance |
| 22 STRATEGY |
| 24 Research & Development: innovating for patients |
| 26 Building the future |
| 28 Industrial Affairs: the power of global capacity |
| 29 Human Resources: rising to the challenges of growth |
| 30 ACTIVITIES |
| 32 A robust and well-adapted model for growth |
| 34 Diabetes: from understanding to action |
| 35 Diversifying therapeutic approaches to cancer |
| 36 Pharmaceutical Customer Solutions: new therapeutic strategies |
| 37 Generics: a broad, well-adapted portfolio |
| 38 Human Vaccines: addressing major public-health concerns |
| 40 Consumer Healthcare: a portfolio of leading global brands |
| 41 Animal Health: a market with a future |
| 42 RESPONSIBILITY |
| 44 A global agenda for corporate responsibility |
| 46 Rising to the challenge of providing more affordable medicines |
| 47 Humanitarian Partnerships: taking healthcare to the most needy |
